Ischemic Myocardial Burden Subtended by Computed Tomography–Derived Fractional Flow Reserve (APPROACHFFRCT): An Exploratory Analysis on Diagnostic Performance

Abdul Rahman Ihdayhid; Bjarne L. Norgaard; Stephan Achenbach; Nancy Khav; Sara Gaur; Jonathan Leipsic; Nitesh Nerlekar; Kazuhiro Osawa; Toru Miyoshi; Jesper M. Jensen; Takeshi Kimura; Hiroki Shiomi; Andrejs Erglis; Keith G. Oldroyd; Hans Erik Botker; Jagat Narula; Brian S. Ko

doi:10.1016/j.jcmg.2020.05.008

Ischemic Myocardial Burden Subtended by Computed Tomography–Derived Fractional Flow Reserve (APPROACH_FFRCT): An Exploratory Analysis on Diagnostic Performance

Abdul Rahman Ihdayhid
, Bjarne L. Norgaard
, Stephan Achenbach
, Nancy Khav
, Sara Gaur
, Jonathan Leipsic
, Nitesh Nerlekar
, Kazuhiro Osawa
, Toru Miyoshi
, Jesper M. Jensen
, Takeshi Kimura
, Hiroki Shiomi
, Andrejs Erglis
, Keith G. Oldroyd
, Hans Erik Botker
, Jagat Narula
, Brian S. Ko

Research output: Contribution to journal › Letter › peer-review

9 Scopus citations

Original language	English
Pages (from-to)	2264-2267
Number of pages	4
Journal	JACC: Cardiovascular Imaging
Volume	13
Issue number	10
DOIs	https://doi.org/10.1016/j.jcmg.2020.05.008
State	Published - Oct 2020
Externally published	Yes

Access to Document

10.1016/j.jcmg.2020.05.008

Cite this

Ihdayhid, A. R., Norgaard, B. L., Achenbach, S., Khav, N., Gaur, S., Leipsic, J., Nerlekar, N., Osawa, K., Miyoshi, T., Jensen, J. M., Kimura, T., Shiomi, H., Erglis, A., Oldroyd, K. G., Botker, H. E., Narula, J., & Ko, B. S. (2020). Ischemic Myocardial Burden Subtended by Computed Tomography–Derived Fractional Flow Reserve (APPROACH_FFRCT): An Exploratory Analysis on Diagnostic Performance. JACC: Cardiovascular Imaging, 13(10), 2264-2267. https://doi.org/10.1016/j.jcmg.2020.05.008

@article{9ceedc76be0d4150b4ded5c725ac8783,

title = "Ischemic Myocardial Burden Subtended by Computed Tomography–Derived Fractional Flow Reserve (APPROACHFFRCT): An Exploratory Analysis on Diagnostic Performance",

author = "Ihdayhid, \{Abdul Rahman\} and Norgaard, \{Bjarne L.\} and Stephan Achenbach and Nancy Khav and Sara Gaur and Jonathan Leipsic and Nitesh Nerlekar and Kazuhiro Osawa and Toru Miyoshi and Jensen, \{Jesper M.\} and Takeshi Kimura and Hiroki Shiomi and Andrejs Erglis and Oldroyd, \{Keith G.\} and Botker, \{Hans Erik\} and Jagat Narula and Ko, \{Brian S.\}",

note = "Funding Information: Please note: Dr. Ihdayhid is supported by the National Health and Medical Research Council of Australia and National Heart Foundation Scholarships. Dr. Ihdayhid has received honoraria from Canon Medical and Boston Scientific. Dr. N{\o}rgaard has received unrestricted institutional research grants from Siemens, Edwards Lifesciences, and HeartFlow. Dr. Achenbach has received research grants from Siemens Healthcare and Bayer. Dr. Leipsic has served as a consultant for Edwards Lifesciences, Circl CVI, and HeartFlow; has served on Speakers Bureau for Philips; has received research support from GE Healthcare; and owns stock options in Circl CVI and HeartFlow. Dr. Jensen has received speaker fees from Bracco Imaging. Dr. Erglis has received institutional research grant support from HeartFlow. Dr. Oldroyd has received consultancy and speaker fees from Abbott and Biosensors. Dr. Ko has received honoraria and speaker fees from Canon Medical, Medtronic, St. Jude Medical, Novartis, Pfizer, Bristol-Myers Squibb, Abbott, and Lilly; and research grant support from Canon Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Please note: Dr. Ihdayhid is supported by the National Health and Medical Research Council of Australia and National Heart Foundation Scholarships. Dr. Ihdayhid has received honoraria from Canon Medical and Boston Scientific. Dr. N{\o}rgaard has received unrestricted institutional research grants from Siemens, Edwards Lifesciences, and HeartFlow. Dr. Achenbach has received research grants from Siemens Healthcare and Bayer. Dr. Leipsic has served as a consultant for Edwards Lifesciences, Circl CVI, and HeartFlow; has served on Speakers Bureau for Philips; has received research support from GE Healthcare; and owns stock options in Circl CVI and HeartFlow. Dr. Jensen has received speaker fees from Bracco Imaging. Dr. Erglis has received institutional research grant support from HeartFlow. Dr. Oldroyd has received consultancy and speaker fees from Abbott and Biosensors. Dr. Ko has received honoraria and speaker fees from Canon Medical, Medtronic, St. Jude Medical, Novartis, Pfizer, Bristol Myers Squibb, Abbott, and Lilly; and research grant support from Canon Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.",

year = "2020",

month = oct,

doi = "10.1016/j.jcmg.2020.05.008",

language = "English",

volume = "13",

pages = "2264--2267",

journal = "JACC: Cardiovascular Imaging",

issn = "1936-878X",

publisher = "Elsevier Inc.",

number = "10",

}

Ihdayhid, AR, Norgaard, BL, Achenbach, S, Khav, N, Gaur, S, Leipsic, J, Nerlekar, N, Osawa, K, Miyoshi, T, Jensen, JM, Kimura, T, Shiomi, H, Erglis, A, Oldroyd, KG, Botker, HE, Narula, J & Ko, BS 2020, 'Ischemic Myocardial Burden Subtended by Computed Tomography–Derived Fractional Flow Reserve (APPROACH_FFRCT): An Exploratory Analysis on Diagnostic Performance', JACC: Cardiovascular Imaging, vol. 13, no. 10, pp. 2264-2267. https://doi.org/10.1016/j.jcmg.2020.05.008

Ischemic Myocardial Burden Subtended by Computed Tomography–Derived Fractional Flow Reserve (APPROACH_FFRCT): An Exploratory Analysis on Diagnostic Performance. / Ihdayhid, Abdul Rahman; Norgaard, Bjarne L.; Achenbach, Stephan et al.
In: JACC: Cardiovascular Imaging, Vol. 13, No. 10, 10.2020, p. 2264-2267.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Ischemic Myocardial Burden Subtended by Computed Tomography–Derived Fractional Flow Reserve (APPROACHFFRCT)

T2 - An Exploratory Analysis on Diagnostic Performance

AU - Ihdayhid, Abdul Rahman

AU - Norgaard, Bjarne L.

AU - Achenbach, Stephan

AU - Khav, Nancy

AU - Gaur, Sara

AU - Leipsic, Jonathan

AU - Nerlekar, Nitesh

AU - Osawa, Kazuhiro

AU - Miyoshi, Toru

AU - Jensen, Jesper M.

AU - Kimura, Takeshi

AU - Shiomi, Hiroki

AU - Erglis, Andrejs

AU - Oldroyd, Keith G.

AU - Botker, Hans Erik

AU - Narula, Jagat

AU - Ko, Brian S.

N1 - Funding Information: Please note: Dr. Ihdayhid is supported by the National Health and Medical Research Council of Australia and National Heart Foundation Scholarships. Dr. Ihdayhid has received honoraria from Canon Medical and Boston Scientific. Dr. Nørgaard has received unrestricted institutional research grants from Siemens, Edwards Lifesciences, and HeartFlow. Dr. Achenbach has received research grants from Siemens Healthcare and Bayer. Dr. Leipsic has served as a consultant for Edwards Lifesciences, Circl CVI, and HeartFlow; has served on Speakers Bureau for Philips; has received research support from GE Healthcare; and owns stock options in Circl CVI and HeartFlow. Dr. Jensen has received speaker fees from Bracco Imaging. Dr. Erglis has received institutional research grant support from HeartFlow. Dr. Oldroyd has received consultancy and speaker fees from Abbott and Biosensors. Dr. Ko has received honoraria and speaker fees from Canon Medical, Medtronic, St. Jude Medical, Novartis, Pfizer, Bristol-Myers Squibb, Abbott, and Lilly; and research grant support from Canon Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Please note: Dr. Ihdayhid is supported by the National Health and Medical Research Council of Australia and National Heart Foundation Scholarships. Dr. Ihdayhid has received honoraria from Canon Medical and Boston Scientific. Dr. Nørgaard has received unrestricted institutional research grants from Siemens, Edwards Lifesciences, and HeartFlow. Dr. Achenbach has received research grants from Siemens Healthcare and Bayer. Dr. Leipsic has served as a consultant for Edwards Lifesciences, Circl CVI, and HeartFlow; has served on Speakers Bureau for Philips; has received research support from GE Healthcare; and owns stock options in Circl CVI and HeartFlow. Dr. Jensen has received speaker fees from Bracco Imaging. Dr. Erglis has received institutional research grant support from HeartFlow. Dr. Oldroyd has received consultancy and speaker fees from Abbott and Biosensors. Dr. Ko has received honoraria and speaker fees from Canon Medical, Medtronic, St. Jude Medical, Novartis, Pfizer, Bristol Myers Squibb, Abbott, and Lilly; and research grant support from Canon Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2020/10

Y1 - 2020/10

UR - https://www.scopus.com/pages/publications/85089300467

U2 - 10.1016/j.jcmg.2020.05.008

DO - 10.1016/j.jcmg.2020.05.008

M3 - Letter

C2 - 32682716

AN - SCOPUS:85089300467

SN - 1936-878X

VL - 13

SP - 2264

EP - 2267

JO - JACC: Cardiovascular Imaging

JF - JACC: Cardiovascular Imaging

IS - 10

ER -